86.21
+3.58(+4.33%)
Currency In USD
| Previous Close | 82.63 |
| Open | 82.09 |
| Day High | 86.29 |
| Day Low | 82.09 |
| 52-Week High | 86.79 |
| 52-Week Low | 40.19 |
| Volume | 971,891 |
| Average Volume | 1.02M |
| Market Cap | 4.34B |
| PE | -18.19 |
| EPS | -4.74 |
| Moving Average 50 Days | 77.13 |
| Moving Average 200 Days | 58.28 |
| Change | 3.58 |
If you invested $1000 in Soleno Therapeutics, Inc. (SLNO) 10 years ago, it would be worth $87.08 as of July 03, 2025 at a share price of $86.21. Whereas If you bought $1000 worth of Soleno Therapeutics, Inc. (SLNO) shares 5 years ago, it would be worth $549.98 as of July 03, 2025 at a share price of $86.21.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Soleno Therapeutics Announces Two Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ENDO 2025
GlobeNewswire Inc.
Jul 01, 2025 12:00 PM GMT
REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that two abstracts featuring da
Soleno Therapeutics Highlights New Data on VYKAT(TM) XR at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire Inc.
Jun 25, 2025 12:00 PM GMT
REDWOOD CITY, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today highlighted new data on VYKATTM XR (diazo
Soleno Therapeutics Announces Multiple Presentations at the 2025 United in Hope: International Prader-Willi Syndrome Conference
GlobeNewswire Inc.
Jun 20, 2025 12:00 PM GMT
Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the Foundation for Prader-Willi Research, and the International Prader-Willi Syndrome OrganisationREDWOOD CITY, Calif., June 20, 2025